Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122
Authors:
Open Access
- 17 April 2021
- journal article
- research article
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 19 (1) , 1-11
Abstract
Background and objectives: Long non-coding RNA (lncRNA) prostate androgen-regulated transcript 1 (PART1) was previously shown to exert an oncogenic role in several human cancers. However, whether PART1 is associated with the malignant progression of pancreatic cancer remains unclear. In the current study, we aimed to identify the role and potential mechanism of PART1 in pancreatic cancer. Methods: qRT-PCR was applied to detect PART1 expression in 45 cases of pancreatic cancer patients. The chi-square test was performed to assess the association between PART1 expression and clinicopathologic features, and Kaplan-Meier method was applied to evaluate overall survival. In vitro CCK-8, transwell invasion, and flow cytometry assays were applied to detect the effects of PART1 on cell proliferation, invasion, and apoptosis, respectively. Luciferase reporter and RNA immunoprecipitation assays were used to identify the regulatory mechanism between PART1 and miR-122. Results: PART1 expression was upregulated in pancreatic cancer tissues and cell lines. High PART1 expression was closely correlated with tumor size, T classification, clinical stage, and vascular invasion, and predicted a poor overall survival. PART1 knockdown significantly suppressed cell proliferation and invasion abilities of pancreatic cancer but promoted cell apoptosis. PART1 was found to serve as a molecular sponge of miR-122, and miR-122 inhibition partially reversed the inhibitory phenotypes of PART1 knockdown on pancreatic cancer cells. Conclusions: PART1 promotes the malignant progression of pancreatic cancer by sponging miR-122. The PART1/miR-122 axis might be a promising target for anticancer therapy in patients with pancreatic cancer.Keywords
This publication has 36 references indexed in Scilit:
- Multiple Functions of Long Non‐Coding RNAs in Oxidative Stress, DNA Damage Response and Cancer ProgressionJournal of Cellular Biochemistry, 2017
- Long Noncoding RNA and Cancer: A New ParadigmCancer Research, 2017
- Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinomaCancer Medicine, 2017
- PART1 expression is associated with poor prognosis and tumor recurrence in stage I-III non-small cell lung cancerJournal of Cancer, 2017
- BCL-2: Long and winding path from discovery to therapeutic targetBiochemical and Biophysical Research Communications, 2017
- Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinomaScientific Reports, 2016
- The multilayered complexity of ceRNA crosstalk and competitionNature, 2014
- Genistein and Daidzein Downregulate Prostate Androgen-Regulated Transcript-1 (PART-1) Gene Expression Induced by Dihydrotestosterone in Human Prostate LNCaP Cancer CellsThe Journal of Nutrition, 2003
- Expression and regulation of prostate androgen regulated transcript-1 (PART-1) and identification of differential expression in prostatic cancerBritish Journal of Cancer, 2001
- PART-1: a novel human prostate-specific, androgen-regulated gene that maps to chromosome 5q12.2000